Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0SSFSR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DM001
|
|||||
| Synonyms |
DM-001; DM 001
Click to Show/Hide
|
|||||
| Organization |
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.; Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 3 Indication(s)
Head and neck cancer [ICD11:2B60-2B6E]
Clinical candidate
Non-small cell lung cancer [ICD11:2C25]
Clinical candidate
Pancreatic cancer [ICD11:2C10]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2); Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.